98%
921
2 minutes
20
Background: Previous studies have shown that mitral annular velocities are reduced in patients with hypertrophic cardiomyopathy (HCM). However, the response of systolic and diastolic velocities of the mitral annulus to exercise in patients with HCM has not been explored previously. Because pathologic left ventricular (LV) hypertrophy is associated with myocardial fibrosis, particularly in the subendocardium, we hypothesized that mitral annular systolic and diastolic velocities during exercise and at rest would be abnormal in patients with HCM.
Methods: Mitral septal annular systolic (S') and early diastolic (E') velocities were measured at rest and during graded supine bicycle exercise (25 W, 3-minute increments) in 40 patients with HCM (29 male, mean age 56 years) and 41 age- and sex-matched control subjects. LV diastolic and systolic longitudinal function reserve index were calculated using a new formula.
Results: There were no significant differences in mitral inflow velocities (early mitral filling velocity [E], E/A, deceleration time of E velocity [DT]) at rest between the two groups except late mitral filling (A) velocity, which was higher in control group. Increase in E' with exercise was significantly smaller in patients with HCM compared with control subjects (1.7 +/- 1.3 vs 3.4 +/- 2.5 cm/s from base to 25 W, P = .0006; 2.2 +/- 1.9 vs 4.5 +/- 2.8 cm/s from base to 50 W, P = .0002). Although LV ejection fraction at rest was significantly higher in patients with HCM compared with that of control subjects (71 +/- 7 vs 66 +/- 7, P = .0019), S' at rest (6.0 +/- 1.2 vs 6.8 +/- 1.1 cm/s, P = .011) was significantly lower in patients with HCM. Although a significant increase in S' was detected with exercise in control subjects, increase in S' with exercise was blunted in patients with HCM (6.4 +/- 1.4 vs 8.5 +/- 2.5 cm/s at 25 W, P = .0004; 7.0 +/- 1.4 vs 9.5 +/- 2.4 cm/s at 50 W, P < .0001). Longitudinal systolic (0.37 +/- 0.85 vs 1.47 +/- 1.75 cm/s at 25 W, P = .0034; 0.79 +/- 1.08 vs 2.32 +/- 1.66 cm/s at 50 W, P = .0001) and diastolic (1.29 +/- 1.06 vs 2.84 +/- 2.12 cm/s at 25 W, P = .0002; 1.63 +/- 1.46 vs 3.77 +/- 2.31 cm/s at 50 W, P < .0001) function reserve index was significantly lower in patients with HCM compared with that of control subjects.
Conclusion: Augmentation of LV longitudinal function during exercise is blunted in patients with HCM, suggesting longitudinal functional reserve and resting longitudinal function is abnormal in these patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.echo.2006.05.022 | DOI Listing |
Cureus
August 2025
Medicine/Cardiology, Madigan Army Medical Center, Tacoma, USA.
Apical hypertrophic cardiomyopathy (ApHCM) is an uncommon, nonobstructive form of hypertrophic cardiomyopathy (HCM) that is associated with an increased risk of ventricular aneurysms, atrial fibrillation, heart failure, and cardiac death. In this case report, a 63-year-old male patient was found to have deeply negative T waves on electrocardiogram (EKG) during a routine preoperative evaluation in an outpatient internal medicine clinic. Imaging with echocardiography and cardiac magnetic resonance confirmed the diagnosis of ApHCM.
View Article and Find Full Text PDFFront Cardiovasc Med
August 2025
Department of Cardiology, Dongguan Tai-xin Hospital, Dongguan, China.
Objective: This study sought to identify key prognostic factors in patients with hypertrophic cardiomyopathy (HCM) and heart failure with preserved ejection fraction (HFpEF), emphasizing the prognostic role of free triiodothyronine (FT3) levels.
Research Design And Methods: This retrospective cohort study enrolled 992 HCM-HFpEF patients from two Chinese medical centers between 2009 and 2019, excluding those with thyroid-affecting medications or disorders. Data on demographic and clinical variables, including FT3, were analyzed using univariate and multivariate Cox regression, Kaplan-Meier (KM) survival analysis, and restricted cubic spline (RCS) analysis to explore prognostic factors and FT3's nonlinear predictive value.
Cardiovasc Endocrinol Metab
December 2025
Department of Endocrinology, Scientific Services, USV Pvt. Ltd, Mumbai, Maharashtra, India.
Background: Co-occurrence of type 2 diabetes mellitus (T2DM) and heart failure (HF) elevates the risk of morbidity and mortality. Recent research emphasizes treatment strategies that go beyond glycemic control to enhance heart function.
Aim: To assess the effectiveness and safety of the fixed-drug combination of dapagliflozin and sitagliptin (FDC D/S) in T2DM patients with HF.
Biomed Eng Lett
September 2025
Department of Cardiovascular Ultrasound, The First Hospital of China Medical University, Shenyang, China.
Abstract: Hypertrophic cardiomyopathy (HCM) is a common hereditary heart disease and is the leading cause of sudden cardiac death in adolescents. Septal hypertrophy (SH) and apical hypertrophy (AH) are two common types. The former is characterized by abnormal septal myocardial thickening and the latter by left ventricular apical hypertrophy, both of which significantly increase the risk of heart failure, arrhythmias, and other serious complications.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
September 2025
Deparment of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address:
Objective: To evaluate the impact of CT planning on surgical myectomy outcomes in patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) and/or mid-cavity obstruction, by comparing these outcomes with those of conventional surgical myectomy.
Methods: This prospective cohort study included patients who underwent surgical septal myectomy for HCM with LVOT and/or mid-cavity obstruction between January 2019 and May 2024 at a single tertiary center. In the CT-planned myectomy group, an expert radiologist simulated the target myectomy site through a series of post-processing methods to plan the surgical approach, provide a surgeon's view that closely resembles the actual perspective in the operating room, and present the target myectomy volume.